Charles River Laboratories

Charles River Laboratories (CRL) is a publicly traded company in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

The company reports trailing twelve-month revenue of $493.97M and net loss of $14.84M.

Key metrics include a return on equity of -0.5%, a debt-to-equity ratio of 1.61.

Investors tracking CRL can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.